| Old Articles: <Older 1981-1990 Newer> |
|---|
 |
Managed Care
April 2005
Thomas Morrow |
Specialty Pharmacy Meets Niche Company Expertise As new specialty pharmacy care becomes more dominant, companies devoted to managing these products and their associated costs are finding a market.   |
The Motley Fool
April 29, 2005
W.D. Crotty |
CNS Has a Nose for Cash The company that gave us Breathe Rights continues to build a large cash hoard. Investors, take note. |
The Motley Fool
April 29, 2005
Charly Travers |
Value in Drug Stocks? Looking at some big pharma companies and liking what you see? Take a peek at biotech, too. GlaxoSmithKline... Pfizer... Amgen... Genzyme... etc. |
The Motley Fool
April 29, 2005
Tim Hanson |
Genentech's Promising Future Cancer drug Avastin is finding new uses. How will outside forces affect its potential? Investors take note. |
BusinessWeek
May 9, 2005
Weintraub & Barrett |
BW 50: Can Caremark's Health Hold Up? Caremark Rx Inc. faces a growing set of legal and market challenges, but Its drug-benefit business is soaring, and its CEO remains upbeat about the future. |
BusinessWeek
May 9, 2005
Catherine Arnst |
Genentech's Lessons For Big Pharma The biotech company focuses on science -- not marketing, acquisitions, or patents. |
InternetNews
April 28, 2005 |
IBM Snares Healthy On-Demand Deal A Pittsburgh medical center will pay IBM $402 million to reload its computing gear and work on new research projects. |
The Motley Fool
April 28, 2005
Stephen D. Simpson |
Novo Nordisk Could Use a Boost Investors reacted badly to first-quarter results, but there's still a lot to like about the Danish pharmaceutical. |
The Motley Fool
April 28, 2005
Stephen D. Simpson |
Standby Drugs Sustain AstraZeneca Sales are good now, but what will a weak pipeline mean to investors in a few years? |
The Motley Fool
April 28, 2005
Charly Travers |
QLT's a Clutch Performer Pharma continues to deliver growth through difficult times. |
| <Older 1981-1990 Newer> Return to current articles. |
